564 related articles for article (PubMed ID: 29059473)
1. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Hay DL; Garelja ML; Poyner DR; Walker CS
Br J Pharmacol; 2018 Jan; 175(1):3-17. PubMed ID: 29059473
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion.
Edvinsson L; Grell AS; Warfvinge K
J Mol Neurosci; 2020 Jun; 70(6):930-944. PubMed ID: 32086679
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
4. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
6. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
7. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins.
Muff R; Born W; Fischer JA
Hypertens Res; 2003 Feb; 26 Suppl():S3-8. PubMed ID: 12630805
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors.
Hay DL; Conner AC; Howitt SG; Smith DM; Poyner DR
J Mol Neurosci; 2004; 22(1-2):105-13. PubMed ID: 14742915
[TBL] [Abstract][Full Text] [Related]
11. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.
Garelja ML; Bower RL; Brimble MA; Chand S; Harris PWR; Jamaluddin MA; Petersen J; Siow A; Walker CS; Hay DL
Br J Pharmacol; 2022 Feb; 179(3):416-434. PubMed ID: 34289083
[TBL] [Abstract][Full Text] [Related]
13. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
14. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
15. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
Roh J; Chang CL; Bhalla A; Klein C; Hsu SY
J Biol Chem; 2004 Feb; 279(8):7264-74. PubMed ID: 14615490
[TBL] [Abstract][Full Text] [Related]
16. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
18. Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor.
Hage La Cour S; Juhler K; Kogelman LJA; Olesen J; Klærke DA; Kristensen DM; Jansen-Olesen I
J Headache Pain; 2022 May; 23(1):59. PubMed ID: 35614383
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
20. Variable CGRP family peptide signaling durations and the structural determinants thereof.
Babin KM; Gostynska SE; Karim JA; Pioszak AA
Biochem Pharmacol; 2024 Jun; 224():116235. PubMed ID: 38670438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
